181 related articles for article (PubMed ID: 24112282)
1. Intravenous antibiotics given for 2 weeks do not eradicate persistent Staphylococcus aureus clones in cystic fibrosis patients.
Andersen C; Kahl BC; Olesen HV; Jensen-Fangel S; Nørskov-Lauritsen N
Clin Microbiol Infect; 2014 May; 20(5):O285-91. PubMed ID: 24112282
[TBL] [Abstract][Full Text] [Related]
2. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
Hansen CR; Pressler T; Hoiby N; Johansen HK
J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
[TBL] [Abstract][Full Text] [Related]
3. Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.
Vanderhelst E; De Wachter E; Willekens J; Piérard D; Vincken W; Malfroot A
J Cyst Fibros; 2013 Dec; 12(6):662-6. PubMed ID: 23706641
[TBL] [Abstract][Full Text] [Related]
4. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients.
Vergison A; Denis O; Deplano A; Casimir G; Claeys G; DeBaets F; DeBoeck K; Douat N; Franckx H; Gigi J; Ieven M; Knoop C; Lebeque P; Lebrun F; Malfroot A; Paucquay F; Pierard D; Van Eldere J; Struelens MJ
J Antimicrob Chemother; 2007 May; 59(5):893-9. PubMed ID: 17341469
[TBL] [Abstract][Full Text] [Related]
5. Rifampicin and sodium fusidate reduces the frequency of methicillin-resistant Staphylococcus aureus (MRSA) isolation in adults with cystic fibrosis and chronic MRSA infection.
Garske LA; Kidd TJ; Gan R; Bunting JP; Franks CA; Coulter C; Masel PJ; Bell SC
J Hosp Infect; 2004 Mar; 56(3):208-14. PubMed ID: 15003669
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of the Copenhagen CF Centre eradication strategy against Staphylococcus aureus in patients with CF.
Dalbøge CS; Pressler T; Høiby N; Nielsen KG; Johansen HK
J Cyst Fibros; 2013 Jan; 12(1):42-8. PubMed ID: 22784398
[TBL] [Abstract][Full Text] [Related]
7. Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient.
Máiz L; Lamas A; Fernández-Olmos A; Suárez L; Cantón R
Pediatr Pulmonol; 2009 May; 44(5):512-5. PubMed ID: 19360847
[TBL] [Abstract][Full Text] [Related]
8. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function.
Ren CL; Morgan WJ; Konstan MW; Schechter MS; Wagener JS; Fisher KA; Regelmann WE;
Pediatr Pulmonol; 2007 Jun; 42(6):513-8. PubMed ID: 17469151
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.
Nadesalingam K; Conway SP; Denton M
J Cyst Fibros; 2005 Mar; 4(1):49-52. PubMed ID: 15752681
[TBL] [Abstract][Full Text] [Related]
10. Paranasal sinus pathogens in children with cystic fibrosis: do they relate to lower respiratory tract pathogens and is eradication successful?
Wilson P; Lambert C; Carr SB; Pao C
J Cyst Fibros; 2014 Jul; 13(4):449-54. PubMed ID: 24713592
[TBL] [Abstract][Full Text] [Related]
11. Microbiologic and therapeutic aspects of Staphylococcus aureus in cystic fibrosis patients.
Bauernfeind A; Hörl G; Przyklenk B
Scand J Gastroenterol Suppl; 1988; 143():99-102. PubMed ID: 3164518
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary infection in mild variant cystic fibrosis: implications for care.
Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
[TBL] [Abstract][Full Text] [Related]
13. High phenotypic diversity in infecting but not in colonizing Staphylococcus aureus populations.
Goerke C; Gressinger M; Endler K; Breitkopf C; Wardecki K; Stern M; Wolz C; Kahl BC
Environ Microbiol; 2007 Dec; 9(12):3134-42. PubMed ID: 17991040
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
[TBL] [Abstract][Full Text] [Related]
15. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
16. Extended Staphylococcus aureus persistence in cystic fibrosis is associated with bacterial adaptation.
Hirschhausen N; Block D; Bianconi I; Bragonzi A; Birtel J; Lee JC; Dübbers A; Küster P; Kahl J; Peters G; Kahl BC
Int J Med Microbiol; 2013 Dec; 303(8):685-92. PubMed ID: 24183484
[TBL] [Abstract][Full Text] [Related]
17. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
[TBL] [Abstract][Full Text] [Related]
18. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis.
Phaff SJ; Tiddens HA; Verbrugh HA; Ott A
J Antimicrob Chemother; 2006 Apr; 57(4):741-6. PubMed ID: 16469851
[TBL] [Abstract][Full Text] [Related]
19. MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?
Downey DG; Kidd TJ; Coulter C; Bell SC
J Cyst Fibros; 2005 Sep; 4(3):205-7. PubMed ID: 16019268
[TBL] [Abstract][Full Text] [Related]
20. Clinical experiences with fusidic acid in cystic fibrosis patients.
Jensen T; Lanng S; Faber M; Rosdahl VT; Høiby N; Koch C
J Antimicrob Chemother; 1990 Feb; 25 Suppl B():45-52. PubMed ID: 2312445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
